TSF PINK CARPET: Dr. John Chen talks eyes, #NMOSD & #MOGAD - what patients should know about vision changes. youtu.be/E42f0B5SiNc
Mayo Clinic's Dr. John Chen Talks Eyes, NMOSD & MOGAD | TSF Pink Carpet
YouTube video by The Sumaira Foundation
youtu.be
November 4, 2026 at 7:19 PM
TSF PINK CARPET: Dr. John Chen talks eyes, #NMOSD & #MOGAD - what patients should know about vision changes. youtu.be/E42f0B5SiNc
New online!
What are the risk factors for relapse in patients diagnosed with AQP4 antibody-positive #NMOSD?
journals.sagepub.com/doi/full/10....
What are the risk factors for relapse in patients diagnosed with AQP4 antibody-positive #NMOSD?
journals.sagepub.com/doi/full/10....
November 2, 2026 at 1:15 AM
New online!
What are the risk factors for relapse in patients diagnosed with AQP4 antibody-positive #NMOSD?
journals.sagepub.com/doi/full/10....
What are the risk factors for relapse in patients diagnosed with AQP4 antibody-positive #NMOSD?
journals.sagepub.com/doi/full/10....
Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD: The Role of Disease Activity in MOGAD. www.neurology.org/doi/10.1212/... #hvhebron #nimm
Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD | Neurology
Background and ObjectivesMultiple sclerosis (MS), myelin oligodendrocyte glycoprotein antibody–associated disease
(MOGAD), and aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder
(AQP...
www.neurology.org
October 27, 2026 at 11:24 AM
Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD: The Role of Disease Activity in MOGAD. www.neurology.org/doi/10.1212/... #hvhebron #nimm
おいしい健康が挑む！NMOSDに関する新しいヘルスケアの提案#ヘルスケア#おいしい健康#NMOSD
ヘルスケアスタートアップ「おいしい健康」がNMOSDに対応した新たなソリューションを提供。障害に立ち向かう健康法とは。
ヘルスケアスタートアップ「おいしい健康」がNMOSDに対応した新たなソリューションを提供。障害に立ち向かう健康法とは。
おいしい健康が挑む！NMOSDに関する新しいヘルスケアの提案
ヘルスケアスタートアップ「おいしい健康」がNMOSDに対応した新たなソリューションを提供。障害に立ち向かう健康法とは。
news.3rd-in.co.jp
October 27, 2026 at 4:29 AM
New clinical trial
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
The goal of this observational study is to learn why some families have several members with multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), or MOG antibody-associated disease (MOGAD). These diseases happen when the immune system attacks the brain, opt...
brain-regeneration.com
October 28, 2026 at 12:40 PM
New clinical trial
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
Morgen moet ik een bultje op mijn neus bij mijn huisarts onder de aandacht brengen. Dat plekje bestaat al zeker tien jaar vrijwel onzichtbaar, maar is sinds prednison en rituximab explosief onrustiger en groter geworden. Misschien ook door de NMOSD. Weetnie. Vink in ieder geval stom. Heb meelij! 🥲
October 26, 2026 at 9:47 PM
Morgen moet ik een bultje op mijn neus bij mijn huisarts onder de aandacht brengen. Dat plekje bestaat al zeker tien jaar vrijwel onzichtbaar, maar is sinds prednison en rituximab explosief onrustiger en groter geworden. Misschien ook door de NMOSD. Weetnie. Vink in ieder geval stom. Heb meelij! 🥲
New research online!
What is the real-world effectiveness and safety of #satralizumab in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder? #NMOSD
journals.sagepub.com/doi/full/10....
What is the real-world effectiveness and safety of #satralizumab in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder? #NMOSD
journals.sagepub.com/doi/full/10....
October 25, 2026 at 5:00 AM
New research online!
What is the real-world effectiveness and safety of #satralizumab in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder? #NMOSD
journals.sagepub.com/doi/full/10....
What is the real-world effectiveness and safety of #satralizumab in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder? #NMOSD
journals.sagepub.com/doi/full/10....
👥 Bringing research closer to patients.
Patient Community Day at #MSToronto2026 brought patients and researchers together to explore MS, NMOSD and MOGAD, ask questions and share experiences.
The programme was available onsite and online, with translations in 50 languages. 💙
Patient Community Day at #MSToronto2026 brought patients and researchers together to explore MS, NMOSD and MOGAD, ask questions and share experiences.
The programme was available onsite and online, with translations in 50 languages. 💙
October 26, 2026 at 11:52 AM
👥 Bringing research closer to patients.
Patient Community Day at #MSToronto2026 brought patients and researchers together to explore MS, NMOSD and MOGAD, ask questions and share experiences.
The programme was available onsite and online, with translations in 50 languages. 💙
Patient Community Day at #MSToronto2026 brought patients and researchers together to explore MS, NMOSD and MOGAD, ask questions and share experiences.
The programme was available onsite and online, with translations in 50 languages. 💙
Backstage with the members of Guns N Roses, Quiet Riot, Danzig and Type O Negative! Need to do some charity work --bring in these guys! #acombatradiochristmascarol #Stop #NMOSD
October 24, 2026 at 2:40 AM
Backstage with the members of Guns N Roses, Quiet Riot, Danzig and Type O Negative! Need to do some charity work --bring in these guys! #acombatradiochristmascarol #Stop #NMOSD
The NMOSD crowd is just happy to be here, call it Shirley for all we care…
October 23, 2026 at 1:14 AM
The NMOSD crowd is just happy to be here, call it Shirley for all we care…
A few legends like @diedrichbader.bsky.social @rogercraigsmith.bsky.social @riccoross.bsky.social @wsalyers.bsky.social @patriciasummersett.bsky.social are getting together to help the kids with #NMOSD and cancer. Check it! Tickets, streaming tickets, info on the flier! #MerryChristmas
October 21, 2026 at 5:35 PM
A few legends like @diedrichbader.bsky.social @rogercraigsmith.bsky.social @riccoross.bsky.social @wsalyers.bsky.social @patriciasummersett.bsky.social are getting together to help the kids with #NMOSD and cancer. Check it! Tickets, streaming tickets, info on the flier! #MerryChristmas
Thank you, ECTRIMS, for having The MOG Project at #ECTRIMS2026! 🩷🩵
Patient Day drew ~4,000 registrants and featured the first-ever dedicated MOGAD and NMOSD panels. We're proud of Julia Lefelar for sharing her lived experience!
Did you tune in? Share your takeaway below!
Patient Day drew ~4,000 registrants and featured the first-ever dedicated MOGAD and NMOSD panels. We're proud of Julia Lefelar for sharing her lived experience!
Did you tune in? Share your takeaway below!
October 23, 2026 at 9:45 PM
Thank you, ECTRIMS, for having The MOG Project at #ECTRIMS2026! 🩷🩵
Patient Day drew ~4,000 registrants and featured the first-ever dedicated MOGAD and NMOSD panels. We're proud of Julia Lefelar for sharing her lived experience!
Did you tune in? Share your takeaway below!
Patient Day drew ~4,000 registrants and featured the first-ever dedicated MOGAD and NMOSD panels. We're proud of Julia Lefelar for sharing her lived experience!
Did you tune in? Share your takeaway below!
Day 2 at #MSToronto2026: predict earlier, diagnose earlier, personalise better. 🧠
From biomarkers and prodromal phases in NMOSD to imaging in MOGAD.
The key: real-world data and patient-reported outcomes must move with it. Patient perspectives belong at the heart of progress.
From biomarkers and prodromal phases in NMOSD to imaging in MOGAD.
The key: real-world data and patient-reported outcomes must move with it. Patient perspectives belong at the heart of progress.
October 22, 2026 at 9:01 PM
Day 2 at #MSToronto2026: predict earlier, diagnose earlier, personalise better. 🧠
From biomarkers and prodromal phases in NMOSD to imaging in MOGAD.
The key: real-world data and patient-reported outcomes must move with it. Patient perspectives belong at the heart of progress.
From biomarkers and prodromal phases in NMOSD to imaging in MOGAD.
The key: real-world data and patient-reported outcomes must move with it. Patient perspectives belong at the heart of progress.
Fascinating work showing immunologic changes years prior to clinical onset of NMOSD. Congrats to all the investigators!
Innate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica
www.biorxiv.org/content/10.6...
Innate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica
www.biorxiv.org/content/10.6...
Innate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica
Neuromyelitis optica spectrum disorder (NMOSD) is a disabling inflammatory central nervous system (CNS) disease characterized by pathogenic aquaporin 4 (AQP4) autoantibodies. The biological events tha...
www.biorxiv.org
October 19, 2026 at 5:29 PM
Fascinating work showing immunologic changes years prior to clinical onset of NMOSD. Congrats to all the investigators!
Innate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica
www.biorxiv.org/content/10.6...
Innate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica
www.biorxiv.org/content/10.6...
Movement is one of the most powerful tools for brain health.
Join our webinar on practical strategies for staying active with MS, NMOSD or MOGAD, with Prof. Philipp Zimmer, @tu-dortmund.de and patient advocate, Janneke Benders.
📅 Thu 29 Oct, 16:00–17:00 CET
👉 Register: bit.ly/4i3b9NL
Join our webinar on practical strategies for staying active with MS, NMOSD or MOGAD, with Prof. Philipp Zimmer, @tu-dortmund.de and patient advocate, Janneke Benders.
📅 Thu 29 Oct, 16:00–17:00 CET
👉 Register: bit.ly/4i3b9NL
October 20, 2026 at 2:45 PM
Movement is one of the most powerful tools for brain health.
Join our webinar on practical strategies for staying active with MS, NMOSD or MOGAD, with Prof. Philipp Zimmer, @tu-dortmund.de and patient advocate, Janneke Benders.
📅 Thu 29 Oct, 16:00–17:00 CET
👉 Register: bit.ly/4i3b9NL
Join our webinar on practical strategies for staying active with MS, NMOSD or MOGAD, with Prof. Philipp Zimmer, @tu-dortmund.de and patient advocate, Janneke Benders.
📅 Thu 29 Oct, 16:00–17:00 CET
👉 Register: bit.ly/4i3b9NL
Per Genentech's Oct 15 release, SatraGO-2 also showed diplopia reduction in 60.7% of Enspryng patients vs 25.8% on placebo. TED is Enspryng's second US indication, after NMOSD in 2020.
October 19, 2026 at 3:25 PM
Per Genentech's Oct 15 release, SatraGO-2 also showed diplopia reduction in 60.7% of Enspryng patients vs 25.8% on placebo. TED is Enspryng's second US indication, after NMOSD in 2020.
#MSToronto2026 - Patients with #NeuromyelitisOptica spectrum disorder who initiated disease-modifying therapy within 90 days of a relapse exhibited a greater probability of confirmed disability improvement.
https://bit.ly/4jkU3gv
https://bit.ly/4jkU3gv
MSToronto2026: Early DMT Initiation May Improve Disability Recovery in NMOSD
Starting disease-modifying therapy within 90 days of a neuromyelitis optica spectrum disorder attack may improve long-term disability recovery.
www.neurologyadvisor.com
October 16, 2026 at 5:11 PM
#MSToronto2026 - Patients with #NeuromyelitisOptica spectrum disorder who initiated disease-modifying therapy within 90 days of a relapse exhibited a greater probability of confirmed disability improvement.
https://bit.ly/4jkU3gv
https://bit.ly/4jkU3gv
Moving more is one of the easiest ways to support brain health, but with MS, NMOSD or MOGAD, fatigue, heat and relapse worries can get in the way.
Prof. Philipp Zimmer, @tu-dortmund.de & advocate Janneke Benders on how to start and keep going.
13 Oct · 16:00 CEST
Register bit.ly/4i3b9NL
Prof. Philipp Zimmer, @tu-dortmund.de & advocate Janneke Benders on how to start and keep going.
13 Oct · 16:00 CEST
Register bit.ly/4i3b9NL
October 16, 2026 at 11:00 AM
Moving more is one of the easiest ways to support brain health, but with MS, NMOSD or MOGAD, fatigue, heat and relapse worries can get in the way.
Prof. Philipp Zimmer, @tu-dortmund.de & advocate Janneke Benders on how to start and keep going.
13 Oct · 16:00 CEST
Register bit.ly/4i3b9NL
Prof. Philipp Zimmer, @tu-dortmund.de & advocate Janneke Benders on how to start and keep going.
13 Oct · 16:00 CEST
Register bit.ly/4i3b9NL
📢 Reminder: One week left until Patient Community Day – which will be LIVE in 50+ languages! Join us for this free event, where experts break down valuable insights in MS, NMOSD & MOGAD research.
🗓️ 23 Oct | 15:00 EDT
Sign up ➡️ www.ectrimspatientcommunity.eu/registration
🗓️ 23 Oct | 15:00 EDT
Sign up ➡️ www.ectrimspatientcommunity.eu/registration
October 15, 2026 at 12:01 PM
📢 Reminder: One week left until Patient Community Day – which will be LIVE in 50+ languages! Join us for this free event, where experts break down valuable insights in MS, NMOSD & MOGAD research.
🗓️ 23 Oct | 15:00 EDT
Sign up ➡️ www.ectrimspatientcommunity.eu/registration
🗓️ 23 Oct | 15:00 EDT
Sign up ➡️ www.ectrimspatientcommunity.eu/registration
LIVE in 1️⃣ week! Join us at Patient Community Day on 23 Oct from 15:00-18:00 EDT, where experts simplify the latest updates in MS, MOGAD & NMOSD research. This is a free event available in 50+ languages. #ECTRIMS4me #ProudSupporters
Sign up here: https://www.ectrimspatientcommunity.eu/registration
Sign up here: https://www.ectrimspatientcommunity.eu/registration
Registration
Register for access to the free recorded livestream from Patient Community Day, which was held on 26 September 2025 in Barcelona, Spain. Learn from top neurological experts about the latest MS research and treatments.
www.ectrimspatientcommunity.eu
October 16, 2026 at 1:21 AM
LIVE in 1️⃣ week! Join us at Patient Community Day on 23 Oct from 15:00-18:00 EDT, where experts simplify the latest updates in MS, MOGAD & NMOSD research. This is a free event available in 50+ languages. #ECTRIMS4me #ProudSupporters
Sign up here: https://www.ectrimspatientcommunity.eu/registration
Sign up here: https://www.ectrimspatientcommunity.eu/registration
El abordaje del #NMOSD va más allá de controlar los brotes. Quince expertos de distintas disciplinas se reúnen para promover una atención integral que contemple el bienestar físico, cognitivo y emocional de quienes viven con esta enfermedad.
us02web.zoom.us/webinar/regi...
us02web.zoom.us/webinar/regi...
October 11, 2026 at 10:06 PM
El abordaje del #NMOSD va más allá de controlar los brotes. Quince expertos de distintas disciplinas se reúnen para promover una atención integral que contemple el bienestar físico, cognitivo y emocional de quienes viven con esta enfermedad.
us02web.zoom.us/webinar/regi...
us02web.zoom.us/webinar/regi...
#WorldSightDay 👁️
For many people with MS, NMOSD and MOGAD, the first symptoms appear in the eyes. NMOSD and MOGAD are often misdiagnosed as MS, and delays can mean permanent vision loss.
EMSP's new #MSBarometer will bring the first Europe-wide data on their care. Coming 2027.
For many people with MS, NMOSD and MOGAD, the first symptoms appear in the eyes. NMOSD and MOGAD are often misdiagnosed as MS, and delays can mean permanent vision loss.
EMSP's new #MSBarometer will bring the first Europe-wide data on their care. Coming 2027.
October 8, 2026 at 11:13 AM
#WorldSightDay 👁️
For many people with MS, NMOSD and MOGAD, the first symptoms appear in the eyes. NMOSD and MOGAD are often misdiagnosed as MS, and delays can mean permanent vision loss.
EMSP's new #MSBarometer will bring the first Europe-wide data on their care. Coming 2027.
For many people with MS, NMOSD and MOGAD, the first symptoms appear in the eyes. NMOSD and MOGAD are often misdiagnosed as MS, and delays can mean permanent vision loss.
EMSP's new #MSBarometer will bring the first Europe-wide data on their care. Coming 2027.
Het is 19°C binnen. Voor mij gevoelsmatig 16°C of zo. Vinter is coming? Vinter is here. Happy NMOSD to me! 🥶
Cat Star Wars Wizard Meme
ALT: Cat Star Wars Wizard Meme
static.klipy.com
October 6, 2026 at 9:33 AM
Het is 19°C binnen. Voor mij gevoelsmatig 16°C of zo. Vinter is coming? Vinter is here. Happy NMOSD to me! 🥶